Obalon Therapeutics Inc.

NASDAQ: OBLN · Real-Time Price · USD
3.05
-0.19 (-5.86%)
At close: Jun 16, 2021, 6:00 AM

Obalon Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2021 Q1 2021
Period Ending Jun 30, 2021 Mar 31, 2021
PE Ratio
-1.85K -1.6
PEG Ratio
18.47 -0.01
PS Ratio
8.16K n/a
PB Ratio
0.50 2.64
P/FCF Ratio
296.96 -6
P/OCF Ratio
98.31 -6
OCF/S Ratio
83.03 n/a
Debt / Equity Ratio
0.01 0.03
Quick Ratio
1.04 1.86
Current Ratio
1.08 1.86
Asset Turnover
0.00 n/a
Interest Coverage
21.52K n/a
Return on Equity
n/a -0.41
Return on Assets
n/a -0.24
Return on Invested Capital
-0.06 -0.38
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
0.61 n/a
Net Profit Margin
-1.11 n/a
Pretax Profit Margin
-1.1 n/a
Operating Profit Margin
-1.05K n/a
FCF Margin
n/a n/a
EBITDA Margin
-36.85 n/a